Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Britton & Koontz Capital Q1 Profit Down

4/23/2012 7:55 PM ET

Britton & Koontz Capital Corp. (BKBK: Quote) reported first-quarter net income of $243 thousand or $0.11 per share, compared to $575 thousand or $0.27 per share in the previous year quarter.

Net interest income declined to $2.4 million from $3.1 million in the same quarter last year, due primarily to lower average earning assets, offset by lower funding costs of interest bearing liabilities.

Non-interest income for the quarter dropped to $729 thousand from $1.53 million in the comparable quarter last year.

Click here to receive FREE breaking news email alerts for Britton & Koontz Capital Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Following the strong upward move seen over the past few sessions, stocks may give back some ground in early trading on Wednesday. The major index futures are currently pointing to a modestly lower open for the markets, with the Dow futures down by 6 points. Eurozone private sector started the second quarter on a solid footing with activity growth the fastest in nearly three years in April, but firms continued to slash prices, fueling fears that deflationary pressures are intensifying. The purchasing managers survey's composite output index rose to 54.0 in April from 53.1 in March, data from Markit Economics showed Wednesday. Researchers have developed a new process to produce large volumes of high quality graphene, described as a wonder material. The new method was developed by a research team led by Prof Jonathan Coleman of AMBER, the Science Foundation Ireland funded materials science center headquartered at Trinity College, Dublin. Graphene is a single-atom thick sheet of carbon. It is extremely light and str
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.